Sample size for 4-period 4-sequence crossover BE study [Power / Sample Size]

posted by Bryony Simmons – UK, 2018-02-01 13:16 (1884 d 15:11 ago) – Posting: # 18320
Views: 20,956


I am in the process of conducting a sample size calculation for a crossover BE study. There are four-treatments (2xreference dosages & 2xtreatment dosages) & I plan to use the Williams' design as follows:


The coefficient of variation from previous studies is 20% & I am assuming the true test reference ratio to be between 0.95 and 1.05. I want to demonstrate bioequivalence (0.80-1.25) at 90% power at the 5% level.

Using these figures, if it was a standard AB/BA crossover, I estimate that I would require 12 individuals to complete each arm - is this correct? I am unsure how this calculation is extended to fit the 4x4 design - do I simply randomise 12 more individuals to each of the remaining two sequences?

Further, if I planned to have just 1 treatment dose changing the design as follows:


Is it reasonable to randomise 12 individuals per sequence?

I really appreciate any help on this question.

Best wishes,

Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

UA Flag
 Admin contact
22,559 posts in 4,725 threads, 1,607 registered users;
21 visitors (0 registered, 21 guests [including 8 identified bots]).
Forum time: 05:27 CEST (Europe/Vienna)

The penalty for scientific irrelevance is, of course,
that the statistician’s work is ignored by the scientific community.    George E.P. Box

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz